Evaluation of Cell-based Non-invasive Prenatal Testing as an Alternative to Chorionic Villus Sampling as a Tool to Confirm the Pregnancy With an Unaffected Fetus Following Preimplantation Genetic Testing
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Aalborg University Hospital
- Enrollment
- 8
- Locations
- 1
- Primary Endpoint
- Agreement between cbNIPT and CVS (The gold standard)
Study Overview
Brief Summary
The study aims to investigate whether cell-based non-invasive prenatal testing (cbNIPT) can be used as an alternative to invasive chorionic villus sampling (CVS) in patients who achieve pregnancy following preimplantation genetic testing for monogenic disorders (PGT-M).
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Primary Purpose
- Diagnostic
- Masking
- None
Eligibility Criteria
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Achieved pregnancy following preimplantation genetic testing
Exclusion Criteria
- Not provided
Arms & Interventions
Intervention group
This arm has blood collected either at the time of CVS.
Intervention: Cell-based non-invasive prenatal testing (Procedure)
Outcomes
Primary Outcomes
Agreement between cbNIPT and CVS (The gold standard)
Time Frame: Immidiately after the results from cbNIPT and CVS has been obtained
How do the cbNIPT results compare to the results of the genetic test following CVS
Secondary Outcomes
- Effectiveness of fetal cell isolation(Immidiately after genetic testing of the isolated fetal cells)
- Effectiveness of testing the genetic variant of interest(Immidiately after genetic testing of the isolated fetal cells)
Investigators
Christian Liebst Frisk Toft
Molecular Biologist, Ph.D. fellow
Aalborg University Hospital
